AI accelerates synthetic biology labs, raising innovation and biosecurity concerns

AI and machine learning are increasingly automating biological laboratories, enabling faster development of drugs and chemicals. While this promises significant innovation, researchers also flag potential biosecurity risks. The development signals a shift in R&D capabilities but remains at an early stage with uncertain regulatory implications.